Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Immunisation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07587801
What this trial is testing

Vaccination Response Modulation With a Targeted Rapamycin Protocol Study

Who this might be right for
Vaccine Immune ResponseHaemodialysis PatientsOlder Adults
Central Adelaide Local Health Network Incorporated 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07508644
What this trial is testing

RSV Vaccination to Reduce Recurrent AECOPD

Who this might be right for
COPDRSV
Chinese University of Hong Kong 320
Not applicableUnknownNCT06511687
What this trial is testing

Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)

Who this might be right for
RSV
Instituto Sistemas Complejos de Ingeniería 160,000
Not applicableUnknownNCT01985620
What this trial is testing

The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.

Who this might be right for
PrematurityRSVInfluenza+2 more
Tel-Aviv Sourasky Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT04785612
What this trial is testing

Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Hvivo 70
Not applicableLooking for participantsNCT06180993
What this trial is testing

Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization

Who this might be right for
RSV Infection
Federico Martinón Torres 42,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06534892
What this trial is testing

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 10,212
Post-approval studies (Phase 4)Study completedNCT05007041
What this trial is testing

Simultaneous RZV and aIIV4 Vaccination

Who this might be right for
PainQuality of LifeInjection Site Reaction+1 more
Duke University 267
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Testing effectiveness (Phase 2)Looking for participantsNCT07050732
What this trial is testing

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

Who this might be right for
Respiratory Syncytial Virus (RSV)
Johns Hopkins University 170
Post-approval studies (Phase 4)Study completedNCT06551506
What this trial is testing

The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 181
Testing effectiveness (Phase 2)Looking for participantsNCT07734649
What this trial is testing

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

Who this might be right for
Respiratory Syncytial Virus ImmunizationHuman Metapneumovirus ImmunizationHealthy Volunteers
Sanofi 2,400
Early research (Phase 1)Active Not RecruitingNCT06564194
What this trial is testing

Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)Infectious Disease
Immorna Biotherapeutics, Inc. 75
Not applicableStudy completedNCT07634692
What this trial is testing

An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia

Who this might be right for
RSV Immunization
Sanofi 257
Testing effectiveness (Phase 2)Study completedNCT05639894
What this trial is testing

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 865
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Not applicableStudy completedNCT06824207
What this trial is testing

Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 2,400
Not applicableActive Not RecruitingNCT07279298
What this trial is testing

Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV in Children Under 6 Months in Bogotá

Who this might be right for
Respiratory Syncytial Virus InfectionsSevere Acute Respiratory InfectionBronchiolitis, Viral+1 more
Bogotá District Health Secretariat 1,097
Large-scale testing (Phase 3)Looking for participantsNCT06955728
What this trial is testing

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Who this might be right for
RSV InfectionsRSV ImmunisationPreterm Labour
University of Witwatersrand, South Africa 13,000
Large-scale testing (Phase 3)Looking for participantsNCT07203365
What this trial is testing

RSV Immunogenicity Study in the Elderly (RISE)

Who this might be right for
RSV Immunisation
Karin Karin Loré 65
Next Page